Brigatinib versus crizotinib in patients with ALK inhibitor–naive advanced ALK+ NSCLC: results from the phase 3 ALTA-1L trial. (January 2020)
- Record Type:
- Journal Article
- Title:
- Brigatinib versus crizotinib in patients with ALK inhibitor–naive advanced ALK+ NSCLC: results from the phase 3 ALTA-1L trial. (January 2020)
- Main Title:
- Brigatinib versus crizotinib in patients with ALK inhibitor–naive advanced ALK+ NSCLC: results from the phase 3 ALTA-1L trial
- Authors:
- Califano, R.
Camidge, D.
Kim, H.-R.
Ahn, M.-J.
Yang, J.
Han, J.-Y.
Hochmair, M.
Lee, K.H.
Delmonte, A.
Campelo, M.R. Garcia
Kim, D.-W.
Griesinger, F.
Felip, E.
Spira, A.
Gettinger, S.
Tiseo, M.
Ni, Q.
Zhang, P.
Popat, S. - Abstract:
- Is Part Of:
- Lung cancer. Volume 139(2020)Supplement 1
- Journal:
- Lung cancer
- Issue:
- Volume 139(2020)Supplement 1
- Issue Display:
- Volume 139, Issue 1 (2020)
- Year:
- 2020
- Volume:
- 139
- Issue:
- 1
- Issue Sort Value:
- 2020-0139-0001-0000
- Page Start:
- S59
- Page End:
- S60
- Publication Date:
- 2020-01
- Subjects:
- Lungs -- Cancer -- Periodicals
Lung Neoplasms -- Abstracts
Lung Neoplasms -- Periodicals
Poumons -- Cancer -- Périodiques
Lungs -- Cancer
Periodicals
Electronic journals
Electronic journals
616.99424 - Journal URLs:
- http://www.sciencedirect.com/science/journal/01695002 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/01695002 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/01695002 ↗
http://www.lungcancerjournal.info/issues ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/S0169-5002(20)30164-1 ↗
- Languages:
- English
- ISSNs:
- 0169-5002
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5307.245000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 12664.xml